Potential impact of combined inhibition of 3α-oxidoreductases and 5α-reductases on prostate cancer
Prostate cancer (PCa) growth and progression rely on the interaction between the androgen receptor (AR) and the testicular ligands, testosterone and dihydrotestosterone (DHT). Almost all men with advanced PCa receive androgen deprivation therapy (ADT). ADT lowers circulating testosterone levels, whi...
Saved in:
| Main Authors: | Michael V. Fiandalo, Daniel T. Gewirth, James L. Mohler |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2019-01-01
|
| Series: | Asian Journal of Urology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2214388218300742 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Medical therapy for clinical benign prostatic hyperplasia: α1 Antagonists, 5α reductase inhibitors and their combination
by: Cheuk Fan Shum, et al.
Published: (2017-07-01) -
Euodia rutaecarpa fruit attenuates testosterone-induced benign
prostatic hyperplasia in rats by inhibiting 5α-reductase activity and
androgen receptor signaling pathway
by: Yung Hyun Choi
Published: (2024-11-01) -
Computational drug discovery of potential 5α-reductase phytochemical inhibitors and hair growth promotion using in silico techniques
by: Behnam Hasannejad-Asl, et al.
Published: (2025-05-01) -
F-actin disassembly by the oxidoreductase MICAL1 promotes mechano-dependent VWF-GPIbα interaction in platelets
by: Jean Solarz, et al.
Published: (2025-08-01) -
Germination Enhances Phytochemical Profiles of Perilla Seeds and Promotes Hair Growth via 5α-Reductase Inhibition and Growth Factor Pathways
by: Anurak Muangsanguan, et al.
Published: (2025-07-01)